A resolution supporting the designation of September 19, 2025, as "National Stillbirth Prevention and Awareness Day", recognizing tens of thousands of families in the United States that have endured a stillbirth, and seizing the opportunity to keep other families from experiencing the same tragedy.

Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); Advancing Safe Medications for Moms and Babies Act; E21 Inclusion of Pregnant and Breastfeeding Women in Clinical Trials Draft Guidance (FDA-2025-D-1797); ;Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); P.L. 119-21, One Big, Beautiful Bill Act; H.R. 1909/S. 2621, Preventing Maternal Deaths Reauthorization Act of 2025; Telemedicine (general); S. 2858/H.R. 5469, SHINE for Autumn Act; S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 2439/H.R4731, Resident Physician Shortage Reduction Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; S. 942/H.R. 2028, REDI Act; Implementation of P.L. 117-328, Pregnant Workers Fairness Act; National Health Service Corps (general); Public Service Loan Forgiveness program (general); maternal mortality review committees (general); HIPAA (general); reductions in force at HHS (general); caps on indirect research costs at NIH (general); removal of CDC online guidance (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); NIH/NICHD womens health research (general); access to fertility services and treatments (general); funding for providers of reproductive health care (general); IUD insertion (general); health IT (general); prepregnancy health (general); Affordable Care Act (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); H.R. 4977/S. 141, Connected MOM Act; S. 2408/H.R. 4648, Access to Fertility Treatment and Care Act; H.R. 4611/S.2377, EACH Act; S. 1599, Midwives for MOMS Act; S. 1562/H.R. 1197, PREEMIE Reauthorization Act; S. 1380/H.R.4681, SPARC Act; S.Res. 401/H.Res. 739, National Stillbirth Prevention and Awareness Day Resolution; H.R. 4331, Access to Claims Data Act; H.R. 4417, Mobile Cancer Screening Act; S.____, Maternal Health Pandemic Response Act; H.R.____, HIV Medication Access Act; United States Preventive Services Taskforce (general); remote blood pressure monitoring (general); pelvic floor therapy (general); Affordable Care Act contraceptive mandate (general); pain management during gynecologic procedures (general); hormone therapy for menopause symptoms (general); acetaminophen use during pregnancy (general); SSRI use during pregnancy (general); federal HIV guidelines (general); HPV testing (general); ; premenstrual dysphoric disorder (general); Pregnancy Risk Assessment Monitoring System (PRAMS); S.2296, National Defense Authorization Act for Fiscal Year 2026; H.R.3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE